![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 53, 37915-37922, December 31, 1999
§,
¶,
,
§§
From the A functional fluorescent neurokinin NK2 receptor
was constructed by joining enhanced green fluorescent protein to the
amino-terminal end of the rat NK2 receptor and was expressed in human
embryonic kidney cells. On cell suspensions, the binding of fluorescent Bodipy-labeled neurokinin A results in a saturatable and reversible decrease of NK2 receptor fluorescence via fluorescence resonance energy
transfer. This can be quantified for nM to
µM agonist concentrations and monitored in parallel with
intracellular calcium responses. On single cells, receptor site
occupancy and local agonist concentration can be determined in real
time from the decrease in receptor fluorescence. Simultaneous
measurement of intracellular calcium responses and agonist binding
reveals that partial receptor site occupancy is sufficient to
desensitize cellular response to a second agonist application to the
same membrane area. Subsequent stimulation of a distal membrane area
leads to a second response to agonist, provided that it had not been
exposed to agonist during the first application. Together with
persistent translocation of fluorescent protein kinase C to the
membrane area exposed to agonist, the present data support that not
only homologous desensitization but also heterologous desensitization
of NK2 receptors is compartmentalized to discrete membrane domains.
Département Récepteurs et
Protéines Membranaires, CNRS UPR 9050, Ecole Supérieure de
Biotechnologie de Strasbourg, Boulevard Sébastien Brant,
67400 Illkirch, France,
Serono Pharmaceutical Research
Institute, 14 chemin des Aulx,
CH-1228 Plan-les-Ouates/Genève, Switzerland, and
** Pharmacologie et Physicochimie des Interactions Cellulaires et
Moléculaires, CNRS UMR 7034, Université Louis Pasteur de
Strasbourg, Faculté de Pharmacie, B.P. 24, 67401 Illkirch,
France
This article has been cited by other articles:
![]() |
E. L. Maillet, N. Pellegrini, C. Valant, B. Bucher, M. Hibert, J.-J. Bourguignon, and J.-L. Galzi A novel, conformation-specific allosteric inhibitor of the tachykinin NK2 receptor (NK2R) with functionally selective properties FASEB J, July 1, 2007; 21(9): 2124 - 2134. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Cluet, C. Bertsch, C. Beyer, L. Gloeckler, M. Erhardt, J.-P. Gut, J.-L. Galzi, and A.-M. Aubertin Detection of Human Immunodeficiency Virus Type 1 Nef and CD4 Physical Interaction in Living Human Cells by Using Bioluminescence Resonance Energy Transfer J. Virol., July 1, 2005; 79(13): 8629 - 8636. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cezanne, S. Lecat, B. Lagane, C. Millot, J.-Y. Vollmer, H. Matthes, J.-L. Galzi, and A. Lopez Dynamic Confinement of NK2 Receptors in the Plasma Membrane: IMPROVED FRAP ANALYSIS AND BIOLOGICAL RELEVANCE J. Biol. Chem., October 22, 2004; 279(43): 45057 - 45067. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Rashid, B. F. O'Dowd, and S. R. George Minireview: Diversity and Complexity of Signaling through Peptidergic G Protein-Coupled Receptors Endocrinology, June 1, 2004; 145(6): 2645 - 2652. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lecat, B. Bucher, Y. Mely, and J.-L. Galzi Mutations in the Extracellular Amino-terminal Domain of the NK2 Neurokinin Receptor Abolish cAMP Signaling but Preserve Intracellular Calcium Responses J. Biol. Chem., October 25, 2002; 277(44): 42034 - 42048. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gicquiaux, S. Lecat, M. Gaire, A. Dieterlen, Y. Mely, K. Takeda, B. Bucher, and J.-L. Galzi Rapid Internalization and Recycling of the Human Neuropeptide Y Y1 Receptor J. Biol. Chem., February 15, 2002; 277(8): 6645 - 6655. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. van der Wal, R. Habets, P. Varnai, T. Balla, and K. Jalink Monitoring Agonist-induced Phospholipase C Activation in Live Cells by Fluorescence Resonance Energy Transfer J. Biol. Chem., April 27, 2001; 276(18): 15337 - 15344. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Valenzuela-Fernandez, T. Palanche, A. Amara, A. Magerus, R. Altmeyer, T. Delaunay, J.-L. Virelizier, F. Baleux, J.-L. Galzi, and F. Arenzana-Seisdedos Optimal Inhibition of X4 HIV Isolates by the CXC Chemokine Stromal Cell-derived Factor 1alpha Requires Interaction with Cell Surface Heparan Sulfate Proteoglycans J. Biol. Chem., July 6, 2001; 276(28): 26550 - 26558. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Palanche, B. Ilien, S. Zoffmann, M.-P. Reck, B. Bucher, S. J. Edelstein, and J.-L. Galzi The Neurokinin A Receptor Activates Calcium and cAMP Responses through Distinct Conformational States J. Biol. Chem., September 7, 2001; 276(37): 34853 - 34861. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |